Skip to main content

Table 1 Vaccination scheme and coverage of the Dutch NIP in 2011

From: Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study

Age

Vaccination 1

Coverage vaccine 1 (%)

Vaccination 2

Coverage vaccine 2 (%)

2 months

DTaP-HBV-IPV/Hib

 

Pneumo

 

3 months

DTaP-HBV-IPV/Hib

 

Pneumo

 

4 months

DTaP-HBV-IPV/Hib

 

Pneumo

 

11 months

DTaP-HBV-IPV/Hib

95.4/96.0

Pneumo

94.8

14 months

MMR

95.9

MenC

95.9

4 years

DTaP-IPV

92.0

  

9 years

DT-IPV

92.2

MMR

92.1

12 years

HPV (3 doses)*

52.5

  
  1. *Only for girls; three doses on 0 days, 1 month and 6 months.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us